Correlation Between Viridian Therapeutics and Compal Electronics

Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Compal Electronics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Compal Electronics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viridian Therapeutics and Compal Electronics GDR, you can compare the effects of market volatilities on Viridian Therapeutics and Compal Electronics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Compal Electronics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Compal Electronics.

Diversification Opportunities for Viridian Therapeutics and Compal Electronics

0.0

Correlation Coefficient

Viridian Therapeutics  Compal Electronics

Pay attention - limited upside

The 3 months correlation between Viridian and Compal is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Compal Electronics GDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compal Electronics GDR and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Compal Electronics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compal Electronics GDR has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Compal Electronics go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Compal Electronics

Assuming the 90 days trading horizon Viridian Therapeutics is expected to generate 1.43 times more return on investment than Compal Electronics. However, Viridian Therapeutics is 1.43 times more volatile than Compal Electronics GDR. It trades about 0.01 of its potential returns per unit of risk. Compal Electronics GDR is currently generating about 0.02 per unit of risk. If you would invest  2,085  in Viridian Therapeutics on September 13, 2024 and sell it today you would lose (167.00) from holding Viridian Therapeutics or give up 8.01% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.42%
Values	Daily Returns

Viridian Therapeutics  vs.  Compal Electronics GDR

Viridian Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Compal Electronics GDR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Compal Electronics GDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Compal Electronics is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Viridian Therapeutics and Compal Electronics

The main advantage of trading using opposite Viridian Therapeutics and Compal Electronics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Compal Electronics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compal Electronics will offset losses from the drop in Compal Electronics' long position.

The idea behind Viridian Therapeutics and Compal Electronics GDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.